SEC 8-K filings, classified by Claude with reasoning. Updated nightly from EDGAR's daily index (~10 PM ET).
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Item 5.01 discloses a change in control of RTB Digital through a Merger Agreement. The filing describes the reconstitution of the Board post-Merger, with multiple director resignations and appointments, and a change in Board size to seven members. This is a material acquisition/change of control event, as evidenced by the Merger Agreement terms governing director transitions and the complete restructuring of the Board composition.
View raw filing on EDGAR →The disclosure centers on the appointment of four executive officers (James Heckman as CEO, Aly Madhavji as CFO, George Oliva as Chief Accounting Officer, and William Sornsin as COO) effective May 21, 2026, following a merger closing. While the section also mentions director resignations, the principal action disclosed is the appointment of a new executive leadership team, which is material to investors assessing post-merger management and governance.
View raw filing on EDGAR →Beta Bionics disclosed updated timeline expectations for commercialization of its lead product candidate, Mint (a patch pump in development), via press release on May 21, 2026. For a development-stage biotech company, material changes to product commercialization timelines are significant to investors assessing the company's path to revenue and capital requirements. This does not fit neatly into the specific event categories (not an earnings release, M&A, impairment, or litigation), making "other_material" the most appropriate classification.
View raw filing on EDGAR →Beta Bionics announced an updated commercialization timeline for its Mint ACE insulin pump, expecting full commercialization by end of Q2 2027 subject to FDA clearance. This is a material product development milestone for a medical device company, but does not fit neatly into the standard 8-K taxonomy (not an earnings release, M&A activity, impairment, or other specific event type). The disclosure would affect investor assessment of the company's near-term revenue prospects and regulatory progress, warranting classification as a material event outside the defined categories.
View raw filing on EDGAR →The disclosure centers on shareholder approval of the Aebi Schmidt Equity Incentive Plan, which authorizes the Board to grant restricted share units, performance share units, and restricted shares to executives, employees, and non-executive Board members. This is a compensatory arrangement disclosure under Item 5.02(e), establishing a material equity compensation framework with 3.5 million shares authorized and performance-based incentive provisions.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder voting results from Aebi Schmidt's Annual Meeting held on May 21, 2026. The filing presents final voting tallies for 11 proposals, including election of directors (Proposal 5.1), approval of audited financial statements (Proposal 1), dividend distribution (Proposal 2.2), and compensation matters (Proposals 9.1–9.5). All proposals were approved by shareholders with strong majorities. This is material as it documents the outcome of fundamental corporate governance actions including board composition and executive compensation approval.
View raw filing on EDGAR →The filing discloses results of an Annual Meeting via press release (Exhibit 99.1) issued on May 21, 2026. This is a classic shareholder_vote_results disclosure under Item 5.07, though filed under Item 7.01 (Regulation FD Disclosure). Annual meeting results are material to investors as they reflect shareholder approval or rejection of key matters such as board elections, compensation, and corporate actions.
View raw filing on EDGAR →This is a standard Item 5.07 disclosure of shareholder voting results from the 2026 Annual Meeting held on May 19, 2026. The filing reports results for five proposals: election of seven directors, approval of an amendment to the 2024 Omnibus Equity Incentive Plan, advisory approval of executive compensation, advisory approval of compensation vote frequency, and ratification of Cherry Bekaert LLP as independent auditors. All proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →The filing discloses an amendment and restatement of Insulet's Bylaws to establish exclusive forum selection provisions for derivative actions, fiduciary duty claims, and Securities Act claims. While bylaw amendments are typically routine administrative matters, forum selection provisions materially affect shareholders' ability to bring litigation and access to courts, which could influence investor assessment of corporate governance and litigation risk. However, this is a standard governance amendment rather than a discrete material event like M&A, restatement, or executive change, warranting classification as other_material rather than a more specific category.
View raw filing on EDGAR →This Item 5.07 discloses the results of Insulet Corp's 2026 Annual Meeting of Stockholders held on May 20, 2026, including voting outcomes for three proposals: election of three Class I directors (Luciana Borio, Michael R. Minogue, Timothy C. Stonesifer), advisory approval of executive compensation (Say-on-Pay), and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (For/Against/Abstentions/Broker Non-Votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder meeting results held on May 20, 2026. The filing presents voting tallies for three proposals: election of 12 directors (with individual vote counts for each nominee), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material governance disclosure.
View raw filing on EDGAR →The disclosure centers on the Board's approval of a new Change in Control Employment Agreement with Vincent P. Berger II, the Executive Vice President and Chief Financial Officer, effective June 1, 2026. The filing details severance benefits, eligibility triggers, and compensation arrangements in the event of a change in control and termination. This is a compensatory arrangement for a named executive officer, replacing a prior agreement that expires on the same date, and would materially affect investor assessment of executive protections and potential costs in a change-of-control scenario.
View raw filing on EDGAR →This Item 5.07 filing discloses the final voting results from HNI Corporation's annual meeting of shareholders held on May 20, 2026. The disclosure covers three proposals: election of three directors (Hartnett, Porcellato, and Sivajee), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation, with detailed vote tallies for each. This is a textbook shareholder_vote_results event.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of three shareholder votes at Bank7 Corp.'s annual meeting held May 20, 2026: election of seven directors, ratification of RSM US LLP as independent auditor for 2026, and advisory approval of 2025 named executive officer compensation. The detailed vote tallies (FOR, AGAINST, ABSTAIN, and broker non-votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →CareTrust REIT completed a public offering of 12.5 million firm shares plus 1.875 million optional shares of common stock at $40.225 per share, totaling approximately 14.375 million shares. The filing discloses the underwriting agreement, exercise of the option, and forward sale agreements executed on May 20-21, 2026. This is a material dilutive equity issuance that would significantly affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →The filing discloses entry into material definitive agreements in connection with the issuance of Asset Backed Notes by Mercedes-Benz Auto Receivables Trust 2026-1 on May 20, 2026. This represents a material securitization transaction involving the creation and issuance of structured debt securities backed by auto receivables, which constitutes a material financing activity requiring Item 1.01 disclosure.
View raw filing on EDGAR →The disclosure describes implementation of a 1-for-10 reverse stock split approved by stockholders on May 11, 2026, effective May 25, 2026. While reverse stock splits modify the capital structure and affect all stockholders uniformly, this event does not fit cleanly into the provided taxonomy categories. It is material to investors as it affects share count, trading mechanics, and CUSIP number, but lacks the specific event-type language of earnings, executive changes, M&A, impairments, or other defined categories. "Other_material" is the appropriate classification for this structural capital event.
View raw filing on EDGAR →VIAVI Solutions conducted a public offering of 11,111,111 shares of common stock at $45.00 per share, with underwriters exercising an additional 1,666,666 shares under the greenshoe option, generating approximately $557.2 million in net proceeds. This is a material registered equity issuance that dilutes existing shareholders and materially affects the company's capital structure and cash position.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on May 20, 2026. The filing reports voting outcomes on four proposals: election of seven directors, ratification of the independent auditor (EisnerAmper LLP), advisory vote on named executive officer compensation, and approval of a stock option exchange program. The detailed vote tallies for each proposal and nominee are the hallmark of shareholder_vote_results classification.
View raw filing on EDGAR →The filing discloses positive Phase 2 clinical trial results for silevertinib in frontline NSCLC patients with EGFR non-classical mutations via press release under Item 7.01 (Regulation FD Disclosure). While this is material clinical development news that would affect investor assessment of the company's pipeline and prospects, it does not fit the earnings_release category (which typically covers financial results) nor any other specific event type in the taxonomy. Clinical trial results are a distinct category of material disclosure for biotech/pharma companies.
View raw filing on EDGAR →Black Diamond Therapeutics announced Phase 2 trial results for silevertinib in frontline NSCLC patients with EGFR non-classical mutations, showing a preliminary median progression-free survival of 15.2 months, ORR of 60%, and no new safety signals. While this is a clinical trial result disclosure, it does not fit the "earnings_release" category (which typically refers to financial results) and is material to investors evaluating the company's pipeline and development prospects. This is classified as "other_material" because it represents a significant clinical milestone for a biotech company's lead candidate that would affect investor assessment of the registrant's value and prospects.
View raw filing on EDGAR →This Item 5.07 discloses the results of a special stockholder meeting held on May 21, 2026, where shareholders voted on the approval of a merger agreement with AC Residential Acquisition LP and related transactions. The Merger Proposal received overwhelming approval (76,820,975 FOR votes vs. 18,230 AGAINST), representing a material change of control event. The filing explicitly presents voting results for multiple proposals, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →The filing discloses a company name change via press release under Item 7.01 (Regulation FD Disclosure). While a name change is a material corporate event that affects investor identification and trading records, the 8-K section provided does not specify the new name or provide substantive details about the change. The disclosure is material to investors but does not fit neatly into the standard taxonomy categories, making "other_material" the most appropriate classification.
View raw filing on EDGAR →The disclosure announces initial clinical trial data (Duravelo-2) for a candidate therapeutic in metastatic urothelial cancer presented at ASCO. For a clinical-stage or development-focused biopharmaceutical company, positive or significant clinical data announcements are material to investors assessing pipeline progress and regulatory prospects. However, this does not fit neatly into the standard taxonomy categories (not earnings, M&A, impairment, litigation, etc.), warranting classification as other_material.
View raw filing on EDGAR →The filing discloses entry into material financing arrangements: an Indenture Supplement dated May 28, 2026 for issuance of "Offered Notes" and a Risk Retention Agreement among First National Bank of Omaha, First National Funding LLC, and First National Master Note Trust. While this involves debt issuance and securitization activity, the Item 8.01 classification and absence of explicit M&A language make it distinct from standard ma_activity. The disclosure of note offerings and related indenture supplements would materially affect investor assessment of the registrant's capital structure and financing activities.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the Annual Meeting of Stockholders held on May 21, 2026, reporting the election of directors (James J. Brady, IV and Eric J. Heagy) and ratification of Wipfli LLP as independent auditor. Item 5.07 is the designated Item for shareholder vote results, and the filing presents final vote tallies for each matter submitted to stockholders.
View raw filing on EDGAR →The filing discloses a "proposed transaction between VYNE and Yarrow" with an S-4 registration statement (File No. 333-294804) filed with the SEC, indicating a material merger or acquisition. The disclosure of an investor presentation by Yarrow Bioscience in connection with this transaction, combined with explicit references to proxy solicitation materials and stockholder voting, confirms this is M&A activity requiring 8-K disclosure under Item 1.01 or related provisions.
View raw filing on EDGAR →The filing discloses Item 5.07 results from Walker & Dunlop's 2026 Annual Meeting of Stockholders held on May 19, 2026, including voting outcomes on three matters: election of eight directors, ratification of KPMG LLP as independent auditor, and an advisory vote on executive compensation. These are standard shareholder vote results that materially inform investors about board composition and governance approvals.
View raw filing on EDGAR →The filing discloses the appointment of Troy Taylor, age 54, to the position of Chief Operating Officer (COO) effective May 20, 2026. This is a material executive appointment under Item 5.02, as the COO is a senior officer responsible for leadership and strategic direction. The filing explicitly states no material compensatory arrangements were entered into, making the appointment itself—not compensation—the principal disclosed event.
View raw filing on EDGAR →Adagio Medical submitted a Premarket Approval (PMA) application to the FDA for its vCLAS® Ventricular Ablation System, a significant regulatory milestone for a medical device company. This event is material to investors as FDA approval is a critical path to commercialization and revenue generation, but it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, litigation, or other defined types). The submission of a major regulatory application represents a material corporate development warranting disclosure under Item 8.01.
View raw filing on EDGAR →The filing discloses a press release announcing "results of operations for the quarter ended March 31, 2026" issued on May 20, 2026, along with a conference call transcript discussing the Financial Results. This is a standard quarterly earnings release disclosure under Regulation FD, furnished as exhibits to the 8-K.
View raw filing on EDGAR →The filing discloses the departure of two senior executives: C. Taylor Pickett (CEO) terminating effective October 1, 2026, and Robert O. Stephenson (CFO) terminating effective August 1, 2026. While the filing also announces successor appointments (Matthew P. Gourmand as CEO and Neal A. Ballew as CFO), the principal disclosed action centers on the departures of these named executives, supported by detailed transition and consulting agreements. This is material to investors as it involves the top two leadership positions.
View raw filing on EDGAR →The Item 7.01 disclosure references "executive transitions described above" but the actual content of those transitions is not provided in this section. The filing indicates a press release was issued announcing executive transitions (Exhibit 99.1), which typically signals either exec_departure or exec_appointment. However, without access to the substantive details of the transitions themselves, the most defensible classification is other_material, as executive transitions are inherently material but the specific nature (departure vs. appointment vs. compensation change) cannot be determined from this boilerplate disclosure language alone.
View raw filing on EDGAR →The Company entered into a new $1.2 billion Five-Year Revolving Credit Agreement on May 15, 2026, replacing a prior $1.0 billion facility. While this represents a material refinancing and increase in available liquidity, it does not fit neatly into the more specific event categories (ma_activity applies to acquisitions/dispositions, not credit facility amendments; covenant_breach applies to violations, not new covenant establishment). The disclosure is material to investors as it affects the Company's financial flexibility and capital structure, but the event is best classified as other_material given the absence of a dedicated taxonomy entry for credit facility amendments or refinancings.
View raw filing on EDGAR →The disclosure reports stockholder approval of an amendment to the Citigroup 2019 Stock Incentive Plan that increases authorized shares available for grant by 20 million shares. This is a compensatory arrangement amendment affecting equity incentive capacity for officers and directors, fitting the exec_compensation category. The material increase in share authorization would affect investor assessment of dilution and executive compensation capacity.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Citigroup's 2026 Annual Meeting of Stockholders held on May 20, 2026, filed under Item 5.07. The section presents detailed voting tallies for four matters: election of 13 directors, ratification of KPMG LLP as independent auditor, advisory vote on 2025 executive compensation, and approval of additional shares for the 2019 Stock Incentive Plan. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →The disclosure reports stockholder approval of the First Amendment to the 2023 Omnibus Incentive Plan, increasing reserved shares by 35 million shares to support equity awards. This is a compensatory arrangement amendment affecting the pool of shares available for executive and employee equity grants, which is a core exec_compensation event under Item 5.02(e). The material increase in share authorization and stockholder approval make this material to investors assessing dilution and compensation practices.
View raw filing on EDGAR →This Item 5.07 disclosure presents the complete voting results from Rithm Capital's Annual Meeting of Stockholders, including election of two Class I directors (David Saltzman and William D. Addas), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the First Amendment. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) are the hallmark of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →The disclosure centers on stockholder approval and adoption of the 2026 Incentive Plan, a compensatory arrangement that governs equity grants, performance awards, and cash-based awards for employees, officers, directors, and consultants. The plan reserves 3.5 million shares and establishes the framework for executive and employee compensation, making this a material executive compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →This is Item 5.07 disclosing the final voting results from Mohawk Industries' Annual Meeting held on May 21, 2026. The section presents tabulated results for four matters voted on: election of three directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the 2026 Plan. These are routine shareholder votes that materially affect corporate governance and executive compensation arrangements.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Target Hospitality Corp.'s 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing presents voting outcomes for four proposals: election of six directors, ratification of Ernst & Young LLP as independent auditor, advisory say-on-pay vote on named executive officer compensation, and approval of a 4,000,000 share increase to the 2019 Incentive Award Plan. All proposals passed with substantial majorities (ranging from 85.45% to 99.95% approval), making this a material disclosure of governance and compensation decisions affecting the registrant.
View raw filing on EDGAR →The filing discloses an award of restricted stock units (RSUs) to non-employee directors on May 21, 2026, with the award agreement filed as an exhibit. This constitutes a compensatory arrangement for directors and falls squarely within exec_compensation, which covers equity grants to named executives and directors. While disclosed under Item 8.01 (Other Events) rather than the typical Item 5.02(e), the substance is a material equity compensation grant.
View raw filing on EDGAR →The disclosure announces EXIM Board approval of a $2.9 billion senior secured long-term loan to support development of the Stibnite Gold Project. While this is a material financing event that would significantly affect investor assessment of the company's capital structure and project funding, it does not fit cleanly into the standard M&A taxonomy categories. The event is neither a traditional acquisition/disposition nor a debt covenant breach or going-concern disclosure, making "other_material" the most appropriate classification for this major project financing approval.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Solid Power's 2026 annual meeting of stockholders held on May 20, 2026, including election of three Class II directors (Steven Goldberg, Aleksandra Miziolek, and MaryAnn Wright), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed voting tallies for each matter are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Merchants Bancorp's Annual Meeting of Shareholders held on May 21, 2026. The filing presents detailed voting tallies for three matters: election of twelve directors, a non-binding advisory vote on named executive officer compensation, and ratification of the independent auditor (Forvis Mazars, LLP). The tabular presentation of votes cast for, against, withheld, abstained, and broker non-votes is the standard format for Item 5.07 disclosures and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →Shawn Canter, Chief Financial Officer of KULR Technology Group, resigned effective May 22, 2026, pursuant to a Separation Agreement. While the disclosure includes compensatory terms (severance, cooperation payments), the principal disclosed action is the departure of a named executive officer from a C-suite position, making exec_departure the most salient classification. The CFO role is material to investor assessment of the company's financial oversight and governance.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from California Water Service Group's Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes on three matters: (1) election of 11 directors, (2) advisory vote on named executive officer compensation, and (3) ratification of Deloitte & Touche LLP as independent auditor. This is the quintessential shareholder_vote_results event type under Item 5.07.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the Company's 2026 Annual Meeting of Stockholders held on May 18, 2026, filed under Item 5.07. The filing reports voting outcomes on three proposals: election of ten directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. All proposals passed with strong majorities (89–99% support), making this a material governance event that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →The filing discloses the closing of a subscription offering in connection with the conversion of Pioneer Federal Savings and Loan Association to a stock bank and the establishment of PSB Financial as its holding company, with the Company's common stock commencing quotation on OTCQB under symbol "PNSB" on May 22, 2026. While this represents a significant corporate restructuring and capital event, it does not fit neatly into the more specific event categories (it is not a traditional M&A activity, dilutive issuance, or earnings release), making "other_material" the most appropriate classification for this material conversion and initial public quotation event.
View raw filing on EDGAR →KKR FS Income Trust issued 206,091.447 Class I shares for approximately $6.024 million in an unregistered private offering under Section 4(a)(2) of the Securities Act and Regulation D. This is a classic dilutive equity issuance to accredited investors outside the registered public offering process, which is material to existing shareholders as it increases share count and dilutes ownership.
View raw filing on EDGAR →